Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells
about
Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARgamma Expression and Activation in Differentiating Mesenchymal Stem CellsInhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitroObesity: Friend or foe for osteoporosisReconstruction of Large-scale Defects with a Novel Hybrid Scaffold Made from Poly(L-lactic acid)/Nanohydroxyapatite/Alendronate-loaded Chitosan Microsphere: in vitro and in vivo Studies.Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.Peptidomimetic small-molecule compounds promoting cardiogenesis of stem cells.Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors.Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women.Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cellsEffects of clodronate combined with hydroxyapatite on multi-directional differentiation of mesenchymal stromal cellsThe effects of zoledronate on the survival and function of human osteoblast-like cellsEffect of Alendronate on Bone Formation during Tooth Extraction Wound Healing.Aging and bone loss: new insights for the clinician.Activated protein C differentially regulates both viability and differentiation of osteoblasts mediated by bisphosphonatesThe bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.Role of the nuclear envelope in the pathogenesis of age-related bone loss and osteoporosis.Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw.Enhanced individual trabecular repair and its mechanical implications in parathyroid hormone and alendronate treated rat tibial bone.P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head.Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.In Vitro and In Vivo Evaluation of Commercially Available Fibrin Gel as a Carrier of Alendronate for Bone Tissue Engineering.In vitro Differentiation Potential of Mesenchymal Stem Cells.Physiology of the aging bone and mechanisms of action of bisphosphonates.The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation.MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro.Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions.Self-assembled monolayers of alendronate on Ti6Al4V alloy surfaces enhance osteogenesis in mesenchymal stem cells.Osteotropic beta-cyclodextrin for local bone regeneration.Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies.Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?Alendronate Can Improve Bone Alterations in Experimental Diabetes by Preventing Antiosteogenic, Antichondrogenic, and Proadipocytic Effects of AGEs on Bone Marrow Progenitor Cells.Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.Differential response of MC3T3-E1 and human mesenchymal stem cells to inositol hexakisphosphate.Differential impact of the bisphosphonate alendronate on undifferentiated and terminally differentiated human myogenic cells.Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells.Clinical implications of bone marrow adiposity.Engineered Multifunctional Nanomedicine for Simultaneous Stereotactic Chemotherapy and Inhibited Osteolysis in an Orthotopic Model of Bone Metastasis.
P2860
Q21342969-640D934A-850A-45B3-8DF5-B00B34AC921BQ24629951-37B1BF45-8756-4E16-92C8-2E7295E3B126Q26863425-DCF8F0F0-2D97-4E5E-834B-8E001C910ECCQ33673415-C9F101BD-B0A8-438F-9975-6C3DA8F25F72Q33838933-AF78FCBD-FD5C-435F-8A68-91C6B38B4915Q34501443-81C49A0B-4E97-45C1-8D77-77CC6A6B77BCQ34636254-9292B4C1-B919-4EA3-8A24-426AB1901837Q34750140-C548A39A-0AF0-4D95-811F-9FF5824B3066Q34967135-3CBE4F71-F7EF-4512-A654-98727FB84493Q35817702-225BF191-C9AC-4C55-BF7E-CBD813BD89C0Q35842418-FBDA897D-2E6F-4EE7-9671-603195DF4B9DQ35990098-B9CC4B7A-EEF0-4A08-A95D-48F3463DC0D4Q36059521-5AC5EFE5-D1C7-4130-B0FE-28304B74BC26Q36645839-FECC43CA-2287-4916-97F7-75D4D67A64A2Q36824444-D014E734-842A-430E-A536-40EFBA9C1C54Q37056325-3DAF68EB-A83B-4147-A544-20BE5D5453A8Q37363602-B1B857B5-B617-47D8-9BAE-3CAEAEB7D5ACQ37370284-6AC51FE2-E736-479E-98E0-6A636EF9B0B2Q37370772-C5C0E62A-9A8F-4F31-9BA2-2740B19A2D9CQ37392009-C642B32A-0F8F-47D4-BDE0-9FD5B730A328Q37562322-4BA09FC6-B5C0-4716-8427-C52AA0D5EE80Q37624975-85B46926-337F-4C08-9714-ED0CACF24E3EQ37872602-FA70EE75-EA2F-4C56-ACB6-ACD7EDF5D7B7Q37892992-D4C5BD1F-E91D-4605-987E-3C9628AF75BEQ39556401-8FFFFDD6-8861-4C23-B762-455041376BFDQ40248368-398991D6-4961-4D19-B374-194F3AE6CAECQ40780414-304F2FFA-2581-44BA-96DB-8FFF5C6484AFQ41696640-98679A36-CB9E-4FC2-8F7A-12391345F3D3Q41849887-F394CBF7-B27B-48A9-8EA0-44B960A8E653Q41866021-B65F2394-4475-47E7-A0CF-42133EB49BD9Q41986545-850EE0D1-2DFD-4399-BA8E-AE3267494664Q42237673-4D9CACB9-8E2B-456E-82CB-F1737232C147Q42374979-B0015C7B-A23F-499C-A7FE-988686D4143FQ42738621-CDE3AB35-1017-4C43-B2CC-FFBBBB19350BQ42828086-A7529AEF-289D-42D4-AF45-DF10E6615702Q43694442-941554A9-7692-4B8C-ADD6-82D4DDF97EECQ45367210-D0F3AA69-2E19-42A4-A135-F2FB1C5D4890Q46277856-59889D7B-D5E1-4595-BA02-EB811F3136E1Q48047130-C82EDA33-DCC2-4910-B0D2-F481E5E681FAQ48333845-39363C69-9C6F-4F9D-9ECD-195B71EFD3EC
P2860
Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@ast
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@en
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@nl
type
label
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@ast
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@en
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@nl
prefLabel
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@ast
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@en
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@nl
P3181
P356
P1476
Alendronate has an anabolic ef ...... tion of mesenchymal stem cells
@en
P2093
Daniel Rivas
P304
P3181
P356
10.1359/JBMR.070701
P407
P577
2007-10-01T00:00:00Z